1. Home
  2. Analysis
  3. Levothyroxine-sodium
  4. Candesartan-cilexetil-and-hydrochlorothiazide

Levothyroxine sodium and Candesartan cilexetil and hydrochlorothiazide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levothyroxine sodium and Candesartan cilexetil and hydrochlorothiazide. Common interactions include anaemia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people who take Levothyroxine sodium and Candesartan cilexetil and hydrochlorothiazide have. It is created by eHealthMe based on reports of 15 people who take Levothyroxine sodium and Candesartan cilexetil and hydrochlorothiazide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 02, 2023

15 people who take Levothyroxine sodium and Candesartan cilexetil and hydrochlorothiazide together, and have interactions are studied.

What is Levothyroxine sodium?

Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 111,499 Levothyroxine sodium users for its effectiveness, alternative drugs and more.

What is Candesartan cilexetil and hydrochlorothiazide?

Candesartan cilexetil and hydrochlorothiazide has active ingredients of candesartan cilexetil; hydrochlorothiazide. eHealthMe is studying from 761 Candesartan cilexetil and hydrochlorothiazide users for its effectiveness, alternative drugs and more.

Number of Levothyroxine sodium and Candesartan cilexetil and hydrochlorothiazide reports submitted per year:

Levothyroxine sodium and Candesartan cilexetil and hydrochlorothiazide drug interactions.

Common Levothyroxine Sodium and Candesartan Cilexetil And Hydrochlorothiazide drug interactions by gender *:

female:

  1. Anaemia
  2. Bicytopenia
  3. Diarrhoea
  4. Hypokalaemia
  5. Suicide attempt
  6. Asthenia
  7. Cardiac valve disease
  8. Dehydration
  9. Dizziness
  10. Hypotension

male:

  1. Anaemia
  2. Blood creatinine increased
  3. Blood urea increased
  4. Neutropenia
  5. Confusional state
  6. Dizziness
  7. Hyponatraemia
  8. Inappropriate antidiuretic hormone secretion
  9. Psychomotor retardation

Common Levothyroxine Sodium and Candesartan Cilexetil And Hydrochlorothiazide drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cardiac valve disease

50-59:

  1. Anaemia
  2. Blood creatinine increased
  3. Blood urea increased
  4. Neutropenia

60+:

  1. General physical health deterioration
  2. Anaemia
  3. Hyponatraemia
  4. Hypotension
  5. Inappropriate antidiuretic hormone secretion
  6. Infusion related reaction
  7. Odynophagia
  8. Palpitations
  9. Psychomotor retardation
  10. Pyrexia

Common conditions people have *:

  1. High Blood Pressure: 5 people, 33.33%
  2. Oesophageal Varices Haemorrhage (bleeding from extremely dilated sub-mucosal veins in the lower third of the oesophagus): 4 people, 26.67%
  3. Hepatitis C: 4 people, 26.67%
  4. Diabetes: 4 people, 26.67%
  5. Ventricular Arrhythmia (problem with the rate or rhythm of the heartbeat): 1 person, 6.67%
  6. Thyroid Diseases: 1 person, 6.67%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%
  8. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 6.67%
  9. Depression: 1 person, 6.67%
  10. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Levothyroxine sodium and Candesartan cilexetil and hydrochlorothiazide?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Levothyroxine sodium and Candesartan cilexetil and hydrochlorothiazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Levothyroxine sodium side effects:

Browse all side effects of Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Levothyroxine sodium interactions:

Browse all interactions between Levothyroxine sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium and candesartan cilexetil; hydrochlorothiazide (the active ingredients of Levothyroxine sodium and Candesartan cilexetil and hydrochlorothiazide, respectively), and Levothyroxine sodium and Candesartan cilexetil and hydrochlorothiazide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Levothyroxine sodium and Candesartan cilexetil and hydrochlorothiazide.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.